Winfield Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-410
| Closed | -$26K | – | 184 |
|
2017
Q4 | $26K | Hold |
410
| – | – | 0.01% | 266 |
|
2017
Q3 | $26K | Hold |
410
| – | – | 0.01% | 256 |
|
2017
Q2 | $23K | Buy |
410
+120
| +41% | +$6.73K | 0.01% | 265 |
|
2017
Q1 | $15K | Sell |
290
-195
| -40% | -$10.1K | 0.01% | 311 |
|
2016
Q4 | $28K | Sell |
485
-115
| -19% | -$6.64K | 0.02% | 225 |
|
2016
Q3 | $32K | Sell |
600
-330
| -35% | -$17.6K | 0.02% | 209 |
|
2016
Q2 | $68K | Buy |
930
+290
| +45% | +$21.2K | 0.04% | 154 |
|
2016
Q1 | $41K | Sell |
640
-170
| -21% | -$10.9K | 0.03% | 187 |
|
2015
Q4 | $56K | Hold |
810
| – | – | 0.04% | 147 |
|
2015
Q3 | $48K | Hold |
810
| – | – | 0.04% | 160 |
|
2015
Q2 | $54K | Hold |
810
| – | – | 0.04% | 157 |
|
2015
Q1 | $52K | Buy |
810
+310
| +62% | +$19.9K | 0.04% | 159 |
|
2014
Q4 | $30K | Hold |
500
| – | – | 0.02% | 183 |
|
2014
Q3 | $26K | Hold |
500
| – | – | 0.02% | 187 |
|
2014
Q2 | $24K | Hold |
500
| – | – | 0.02% | 204 |
|
2014
Q1 | $26K | Buy |
+500
| New | +$26K | 0.02% | 186 |
|